Publications by authors named "Ken Harvey"

Claim this Profile
T
The Australian obesity epidemic and the regulation of complementary medicine weight loss products.
Ken Harvey

Aust N Z J Public Health· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary medicines advertising policy Part II: unethical conduct in the Australian market after July 2018.
Ken Harvey, Malcolm Vickers, Bruce Baer Arnold

Aust Health Rev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary medicines advertising policy Part I: unethical conduct in the Australian market before July 2018.
Malcolm Vickers, Ken Harvey

Aust Health Rev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of complementary medicines.
Ken Harvey

Intern Med J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retail genetics.
Ken Harvey, Basia Diug

Aust Prescr· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling and encoding Therapeutic Guidelines: applying ICD-10-AM and European Article Number codes.
Bryn Lewis, Ken Harvey, Jonathan Dartnell, Jennie Shepheard

Health Inf Manag· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"I want to consume this product; should public health experts stop me?"--Yes--Opposing views.
Ken J Harvey

Med J Aust· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?
Ken J Harvey, Richard O Day, William G Campbell, Wendy Lipworth

Med J Aust· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxycut hepatotoxicity. Comment.
Ken J Harvey

Med J Aust· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of features of electronic prescribing systems to support quality and safety in primary care using a modified Delphi process.
Michelle Sweidan, Margaret Williamson, James F Reeve, Ken Harvey, Jennifer A O'Neill

BMC Med Inform Decis Mak· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of proposals to reform the regulation of complementary medicines.
Ken J Harvey

Aust Health Rev· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commercialism, choice and consumer protection: regulation of complementary medicines in Australia.
Ken J Harvey, Viola S Korczak, Loretta J Marron, David B Newgreen

Med J Aust· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?
Ken J Harvey, Anthony H Harris, Liliana Bulfone

Med J Aust· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-label use of medicines: consensus recommendations for evaluating appropriateness.
Allen C Cheng, Priscilla M Robinson, Ken Harvey

Med J Aust· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational antibiotic use in China: lessons learnt through introducing surgeons to Australian guidelines.
Yan Zhang, Ken Harvey

Aust New Zealand Health Policy· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical advertisements in prescribing software: an analysis.
Ken J Harvey, Agnes I Vitry, Elizabeth Roughead, Rosalie Aroni, Nicola Ballenden

Med J Aust· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pharmaceutical Benefits Scheme 2003-2004.
Ken J Harvey

Aust New Zealand Health Policy· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme.
Ken Harvey

Aust Health Rev· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Croatian pharmaceutical sector reform project: rational drug use.
Ken Harvey, Karolina Kalanj, Ranko Stevanović

Croat Med J· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?
Ken J Harvey, Thomas A Faunce, Buddhima Lokuge, Peter Drahos

Med J Aust· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes management of an ambulatory clinic system population: experience with patients with diabetes.
Dana Walker, Ken Harvey

J Miss State Med Assoc· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving antibiotic use: 25 years of antibiotic guidelines and related initiatives.
Ken Harvey, Jonathan Dartnell, Mary Hemming

Commun Dis Intell Q Rep· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eTG complete.
Ken J Harvey

Med J Aust· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis